© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Pacific Edge chief executive David Darling says he was astounded by the recent sharp fall in the company’s share price coinciding with his and director Chris Swann's sales of small parcels of shares.
The Dunedin-based biomed company [PEB:NZX], which was a darling of the market a month ago
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Duncan Bridgeman
Fri, 14 Mar 2014
Fri, 14 Mar 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Pacific Edge boss explains his share sale, says market overreacted
36499